PF-06940434
N/A
Report date: 2026/03/20 20:03:07
Base Information
Drug NamePF-06940434
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications +[12]
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[6]
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesPfizer Inc
China Registration ClassN/A
Develop Information
Active CompaniesPfizer IncPfizer Investment Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive Indications +[11]
Other Information
ATC CodeN/A
Related LinksN/A